ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis

Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy

(2017) Xiao-Qin Li et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis

(2011) Gerold Bepler et al.   AMERICAN JOURNAL OF PATHOLOGY

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial

(2010) A. C. Vilmar et al.   ANNALS OF ONCOLOGY

High-Level mRNA of Excision Repair Cross-Complementation Group 1 Gene Is Associated With Poor Outcome of Platinum-Based Doublet Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients

(2010) Shengxiang Ren et al.   CANCER INVESTIGATION

Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells

(2009) Jen-Chung Ko et al.   BIOCHEMICAL PHARMACOLOGY

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation

(2009) Koichi Azuma et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Expression of MRP1, BCRP, LRP, and ERCC1 in Advanced Non–Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival

(2009) Jian Li et al.   Clinical Lung Cancer

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

(2009) Craig Reynolds et al.   JOURNAL OF CLINICAL ONCOLOGY

Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non–Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine

(2009) Bente Holm et al.   JOURNAL OF CLINICAL ONCOLOGY

Excision Repair Cross Complementation Group 1 Polymorphisms Predict Overall Survival after Platinum-Based Chemotherapy for Completely Resected Non-Small-Cell Lung Cancer

(2009) Katsuhiro Okuda et al.   JOURNAL OF SURGICAL RESEARCH

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy

(2009) Hyun Woo Lee et al.   LUNG CANCER

Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy

(2009) Jian Li et al.   LUNG CANCER

The prognostic significance of ERCC1, BRCA1, XRCC1, and βIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection

(2009) Chang Hyun Kang et al.   LUNG CANCER

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

(2009) Xin Wang et al.   MEDICAL ONCOLOGY

Expression of ERCC1 and class IIIβ tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer

(2009) Satoshi Ikeda et al.   PATHOLOGY INTERNATIONAL

Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer

(2008) Katsuhiro Okuda et al.   LUNG CANCER

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy

(2008) Shuji Ota et al.   LUNG CANCER

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

(2008) Koichi Azuma et al.   LUNG CANCER

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literature

(2008) Adam Vilmar et al.   LUNG CANCER

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

(2007) Kyung-Hun Lee et al.   LUNG CANCER

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer

(2007) Tetsuya Fujii et al.   LUNG CANCER